- Program
-
Sessions
- Welcome Introduction Symposium
- Aldosterone and mineralocortoid receptors: expanding views from the kidney to the cardiovascular system.
- Overexpression of the mineralocorticoid receptors: pathophysiological consequences
- Questions and Answers
- Mineralocorticoid receptor blockade: how experimental evidence supports the clinical benefit
- Questions and Answers
- The proximate cause of heart failure: models, remodeling, and re-remodeling
- Questions and Answers
- After RALES, the journey continues
- Questions and Answers
- Efficacy of spironolactone in dogs with naturally occurring Myxomatous Mitral Valve Disease. (part I)
- Efficacy of spironolactone in dogs with naturally occurring Myxomatous Mitral Valve Disease. (part II)
- Principles of survival analysis illustrated by CEVA’s spironolactone trials
- Questions and Answers
- Current clinical status and future directions for biomarkers in heart failure
- Questions and Answers
- Conclusion Symposium
- TEST
- Speakers
- Footer links
CARDIO SYMPOSIUM 2009
